We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.76B
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+0.05%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$3.55B
AUM Growth
+$59.4M
Cap. Flow
-$31.8M
Cap. Flow %
-0.9%
Top 10 Hldgs %
49.57%
Holding
665
New
156
Increased
155
Reduced
111
Closed
128
Avg Time Held Equity + Options
3.9 quarters
Top 10 Avg Time Held Equity + Options
0.8 quarters
Top 20 Avg Time Held Equity + Options
1.2 quarters
Avg Time Held Equity only
4.3 quarters
Top 10 Avg Time Held Equity only
0.8 quarters
Top 20 Avg Time Held Equity only
1.2 quarters

Top Buys

Rank Stock Value
1
HCP icon
HashiCorp, Inc. Class A Common Stock
HCP
+$138M
2
ETRN icon
Equitrans Midstream Corporation Common Stock
ETRN
+$131M
3
EDR icon
Endeavor Group Holdings, Inc.
EDR
+$127M
4
MRO icon
Marathon Oil Corporation
MRO
+$123M
5
CHX icon
ChampionX
CHX
+$98.3M

Top Sells

Rank Stock Value
1
PXD icon
Pioneer Natural Resource Co.
PXD
+$638M
2
CERE icon
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
+$51.2M
3
DFS icon
Discover Financial Services
DFS
+$45.1M
4
SCRM icon
Screaming Eagle Acquisition Corp. Class A Ordinary Shares
SCRM
+$18.4M
5
NSC icon
Norfolk Southern
NSC
+$17.7M

Sector Composition

Rank Sector Weight
1 Energy 26.53%
2 Technology 21.03%
3 Healthcare 14.68%
4 Industrials 8.19%
5 Miscellaneous 6.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
MGM icon
301
PUT
MGM Resorts International
MGM
$7.36B
$870K 0.02%
250,000
+175,000
+233% +$7.31M
2023 Q1
5 quarters
SHOP icon
302
Shopify
SHOP
$220B
$859K 0.02%
13,000
+6,500
+100% +$431K
2024 Q1
1 quarter
RAMP icon
303
LiveRamp
RAMP
$2.28B
$851K 0.02%
27,500
-157,500
-85% -$5.06M
2024 Q1
1 quarter
CATX icon
304
Perspective Therapeutics
CATX
$304M
$848K 0.02%
+85,013
New +$1.23M
2024 Q2
0 quarters
TFX icon
305
Teleflex
TFX
$5.3B
$841K 0.02%
+4,000
New +$838K
2024 Q2
0 quarters
RVNC icon
306
DELISTED
Revance Therapeutics, Inc.
RVNC
$836K 0.02%
325,314
+70,647
+28% +$241K
2023 Q3
3 quarters
GTM icon
307
ZoomInfo Technologies
GTM
$1.13B
$830K 0.02%
+65,000
New +$909K
2024 Q2
0 quarters
PLRX icon
308
Pliant Therapeutics
PLRX
$63.2M
$828K 0.02%
+77,000
New +$993K
2024 Q2
0 quarters
TEVA icon
309
Teva Pharmaceutical Industries Limited
TEVA
$47.9B
$827K 0.02%
50,896
+6,000
+13% +$92.4K
2023 Q3
3 quarters
TCOM icon
310
Trip.com Group
TCOM
$24.5B
$823K 0.02%
17,500
-347,500
-95% -$17.7M
2023 Q2
4 quarters
RGNX icon
311
Regenxbio
RGNX
$533M
$821K 0.02%
+70,199
New +$1.09M
2024 Q2
0 quarters
SONO icon
312
Sonos
SONO
$2.04B
$812K 0.02%
55,000
+15,000
+38% +$249K
2024 Q1
1 quarter
QURE icon
313
uniQure
QURE
$1.57B
$811K 0.02%
180,939
+109,875
+155% +$535K
2022 Q4
6 quarters
ORIC icon
314
Oric Pharmaceuticals
ORIC
$1.24B
$809K 0.02%
114,366
+22,000
+24% +$197K
2022 Q2
8 quarters
ARVN icon
315
Arvinas
ARVN
$500M
$807K 0.02%
30,301
-1,200
-4% -$38.2K
2023 Q1
5 quarters
STRO icon
316
Sutro Biopharma
STRO
$237M
$806K 0.02%
27,506
+2,000
+8% +$79.1K
2023 Q3
3 quarters
CNTB icon
317
Connect Biopharma Holdings
CNTB
$54.8M
$776K 0.02%
510,701
– –
2022 Q2
8 quarters
RIGL icon
318
Rigel Pharmaceuticals
RIGL
$917M
$760K 0.02%
92,448
+25,173
+37% +$263K
2022 Q1
9 quarters
MTCH icon
319
Match Group
MTCH
$9.43B
$760K 0.02%
25,000
-10,000
-29% -$316K
2023 Q1
5 quarters
O icon
320
Realty Income
O
$51.3B
$755K 0.02%
+14,300
New +$764K
2024 Q2
0 quarters
CRC icon
321
California Resources
CRC
$4.7B
$748K 0.02%
14,046
-490
-3% -$25K
2020 Q4
14 quarters
AVB icon
322
DELISTED
AvalonBay Communities
AVB
$745K 0.02%
+3,600
New +$696K
2024 Q2
0 quarters
ZM icon
323
Zoom
ZM
$28.5B
$740K 0.02%
12,500
-15,000
-55% -$921K
2023 Q1
5 quarters
PODD icon
324
Insulet
PODD
$9.38B
$736K 0.02%
3,647
-5,200
-59% -$937K
2023 Q3
3 quarters
DNLI icon
325
Denali Therapeutics
DNLI
$3.11B
$732K 0.02%
31,517
+6,484
+26% +$124K
2023 Q2
4 quarters
11 12
13
14 15

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return
JCM
Janney Capital Management Pittsburgh, Pennsylvania $1.59B AUM 23.25% 1-Year Est. Return
MPM
Meritage Portfolio Management Overland Park, Kansas $1.51B AUM 26.61% 1-Year Est. Return

UBS O'Connor's Q2 2024 Portfolio in Review

As of Q2 2024, UBS O'Connor held 665 positions worth $3.55B, up 1.7% from $3.49B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

UBS O'Connor's Q2 2024 filing shows 156 new, 155 increased, 111 reduced and 128 closed positions. Its largest new stake was Endeavor Group Holdings, Inc.: 4,789,930 shares worth $129M. The largest sale was Pioneer Natural Resource Co., an estimated $638M.

By sector, the portfolio is most concentrated in Energy at 27% of assets, down from 34% a quarter earlier, followed by Technology and Healthcare.

  • UBS O'Connor's largest Q2 2024 buy was Endeavor Group Holdings, Inc.: 4,789,930 shares worth $129M.
  • UBS O'Connor added most to HashiCorp, Inc. Class A Common Stock in Q2 2024, an estimated $138M increase.
  • UBS O'Connor's biggest Q2 2024 reduction was Cerevel Therapeutics Holdings, Inc. Common Stock, cutting an estimated $51.2M.
  • UBS O'Connor fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $638M.
  • UBS O'Connor's ten largest holdings make up 50% of its $3.55B portfolio in Q2 2024.
  • UBS O'Connor opened 156 new positions and closed 128 in Q2 2024.
  • UBS O'Connor's portfolio value rose 1.7% quarter-over-quarter to $3.55B.

Based on UBS O'Connor's 13F filing for Q2 2024, filed 14 Aug 2024.